We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Siemens Healthineers Commissioned to Provide Lab Services for Turkish Hospitals

By LabMedica International staff writers
Posted on 09 Feb 2017
Siemens Healthineers has entered into a five-year contract to take over the clinical laboratory service operations for two new hospitals in Turkey. More...
The hospitals in Bilkent, Ankara, and in Mersin are being built and operated as Public Private Partnership (PPP) by DiA Construction, a subsidiary of DiA, for the Turkish Ministry of Health.

The new hospitals are expected to improve healthcare as part of a Turkish government program to restructure the country's healthcare system, which began in 2003. According to the Turkish government, the Bilkent health campus, which has nearly 3,800 beds and an affiliated hotel, congress center and commercial area, is the largest project in the healthcare sector to be ever constructed from scratch in the country. From mid-2018, over 10,000 medical staff will manage almost 25,000 patients daily at the Bilkent health campus, while the hospital in Mersin, which became operational towards the end of January 2017, will hold about 1,300 beds.

Siemens Healthineers will operate the laboratories at both the hospitals in partnership with lab doctors from Turkey's Ministry of Health. The company will assume the laboratory services for biochemistry, microbiology, hematology, immunology, emergency, genetics, pathology and point of care testing within these hospitals. It also will provide the design, medical and technical equipment, appliances, consumables, service and maintenance, apart from the laboratory technical staff. The contract is expected to grant minimum revenue of nearly Euro 30 million, based on guaranteed annual test volumes, and is likely to surpass Euro 100 million, based on anticipated test volumes.

"It was important for us to have a partner that not only came with enough experience in the hospital environment, but also was strong on technical innovation," said Hakan Adanalı, Director of Clinical Support Services in DiA. "We expect, that around 92 million patients will benefit from the partnership over the next five years."

"This project combines our expertise in equipping laboratories with our service portfolio. It is a milestone for us and, at the same time, also a proof point for how we enable our customers to meet their current challenges and to excel in their respective environments. The new business model is designed to support our customers in increasing efficiency and containing costs right from the beginning," said Bernd Montag, Chief Executive Officer, Siemens Healthineers. "We have developed a customized solution for our partner DiA and the Turkish Ministry of Health that will comprehensively support their clinical business. This order will strengthen our portfolio and is consistent with our strategy."


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Portable Electronic Pipette
Mini 96
Specimen Radiography System
TrueView 200 Pro
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The study highlights the potential of cCAFs as a biomarker for early diagnosis and prognosis (H J Woo et al., Analytical Chemistry (2025). DOI: 10.1021/acs.analchem.5c02154)

Simultaneous Cell Isolation Technology Improves Cancer Diagnostic Accuracy

Accurate cancer diagnosis remains a challenge, as liquid biopsy techniques often fail to capture the complexity of tumor biology. Traditional systems for isolating circulating tumor cells (CTCs) vary in... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.